TY - JOUR
T1 - FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer
AU - Wang, Zifeng
AU - Townley, Scott L.
AU - Zhang, Songqi
AU - Liu, Mingyu
AU - Li, Muqing
AU - Labaf, Maryam
AU - Patalano, Susan
AU - Venkataramani, Kavita
AU - Siegfried, Kellee R.
AU - Macoska, Jill A.
AU - Han, Dong
AU - Gao, Shuai
AU - Risbridger, Gail P.
AU - Taylor, Renea A.
AU - Lawrence, Mitchell G.
AU - He, Housheng Hansen
AU - Selth, Luke A.
AU - Cai, Changmeng
PY - 2024/6/8
Y1 - 2024/6/8
N2 - FOXA family proteins act as pioneer factors by remodeling compact chromatin structures. FOXA1 is crucial for the chromatin binding of the androgen receptor (AR) in both normal prostate epithelial cells and the luminal subtype of prostate cancer (PCa). Recent studies have highlighted the emergence of FOXA2 as an adaptive response to AR signaling inhibition treatments. However, the role of the FOXA1 to FOXA2 transition in regulating cancer lineage plasticity remains unclear. Our study demonstrates that FOXA2 binds to distinct classes of developmental enhancers in multiple AR-independent PCa subtypes, with its binding depending on LSD1. Moreover, we reveal that FOXA2 collaborates with JUN at chromatin and promotes transcriptional reprogramming of AP-1 in lineage-plastic cancer cells, thereby facilitating cell state transitions to multiple lineages. Overall, our findings underscore the pivotal role of FOXA2 as a pan-plasticity driver that rewires AP-1 to induce the differential transcriptional reprogramming necessary for cancer cell lineage plasticity.
AB - FOXA family proteins act as pioneer factors by remodeling compact chromatin structures. FOXA1 is crucial for the chromatin binding of the androgen receptor (AR) in both normal prostate epithelial cells and the luminal subtype of prostate cancer (PCa). Recent studies have highlighted the emergence of FOXA2 as an adaptive response to AR signaling inhibition treatments. However, the role of the FOXA1 to FOXA2 transition in regulating cancer lineage plasticity remains unclear. Our study demonstrates that FOXA2 binds to distinct classes of developmental enhancers in multiple AR-independent PCa subtypes, with its binding depending on LSD1. Moreover, we reveal that FOXA2 collaborates with JUN at chromatin and promotes transcriptional reprogramming of AP-1 in lineage-plastic cancer cells, thereby facilitating cell state transitions to multiple lineages. Overall, our findings underscore the pivotal role of FOXA2 as a pan-plasticity driver that rewires AP-1 to induce the differential transcriptional reprogramming necessary for cancer cell lineage plasticity.
KW - Cancer epigenetics
KW - Prostate cancer
UR - http://www.scopus.com/inward/record.url?scp=85195430087&partnerID=8YFLogxK
U2 - 10.1038/s41467-024-49234-9
DO - 10.1038/s41467-024-49234-9
M3 - Article
C2 - 38851846
AN - SCOPUS:85195430087
SN - 2041-1723
VL - 15
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 4914
ER -
